Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

por Batson, Sarah, Mitchell, Stephen A, Windisch, Ricarda, Damonte, Elisabetta, Munk, Veronica C, Reguart, Noemi
Publicado 2017

Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, R...

por Rosen, Virginia M., Guerra, Ines, McCormack, Mary, Nogueira-Rodrigues, Angélica, Sasse, Andre, Munk, Veronica C., Shang, Aijing
Publicado 2017